These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2707972)

  • 21. Conformational studies of cyclic tetrapeptides. Evidence for a bis gamma-turn conformation for chlamydocin and Ala4-chlamydocin in nonpolar solvents.
    Rich DH; Kawai M; Jasensky RD
    Int J Pept Protein Res; 1983 Jan; 21(1):35-42. PubMed ID: 6826281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformations of proline-containing cyclic peptides. 1H and 13C n.m.r. evidence for a solvent stabilized All-Cis X-Pro conformer of Cyclo-(Pro-Gly-Gly-Pro)2.
    Hollósi M; Radics L; Wieland T
    Int J Pept Protein Res; 1977 Oct; 10(4):286-90. PubMed ID: 591178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure and molecular conformation of the hydrated cyclic hexapeptide cyclo(L-Ala-L-Pro-D-Phe)2.
    Brown JN; Teller RG
    J Am Chem Soc; 1976 Nov; 98(24):7565-9. PubMed ID: 993495
    [No Abstract]   [Full Text] [Related]  

  • 24. Conformation-activity relationships of cyclo-constrained micro/delta opioid agonists derived from the N-terminal tetrapeptide segment of dermorphin/deltorphin.
    Rodziewicz-Motowidło S; Czaplewski C; Luczak S; Ciarkowski J
    J Pept Sci; 2008 Aug; 14(8):898-902. PubMed ID: 18338322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic peptides. XIV. Syntheses of [4-l-leucine]-, [4-D-leucine]-, and [3-L-proline, 4-D-leucine]-Cyl-2.
    Yasutake A; Aoyagi H; Sada I; Kato T; Izumiya N
    Int J Pept Protein Res; 1982 Sep; 20(3):246-53. PubMed ID: 7129757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon-13 NMR studies of EM 49 and related octapeptins.
    Puar MS
    J Antibiot (Tokyo); 1980 Jul; 33(7):760-3. PubMed ID: 7410218
    [No Abstract]   [Full Text] [Related]  

  • 27. Conformational mobility in cyclic oligopeptides.
    Kopple KD; Bean JW; Bhandary KK; Briand J; D'Ambrosio CA; Peishoff CE
    Biopolymers; 1993 Jul; 33(7):1093-9. PubMed ID: 8102073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational behaviour of a cyclolinopeptide A analogue: two-dimensional NMR study of cyclo(Pro1-Pro-Phe-Phe-Ac6c-Ile-ala-Val8).
    Mazzeo M; Isernia C; Rossi F; Saviano M; Pedone C; Paolillo L; Benedetti E; Pavone V
    J Pept Sci; 1995; 1(5):330-40. PubMed ID: 9223012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists.
    Boer J; Gottschling D; Schuster A; Semmrich M; Holzmann B; Kessler H
    J Med Chem; 2001 Aug; 44(16):2586-92. PubMed ID: 11472212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
    Lomize AL; Pogozheva ID; Mosberg HI
    Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of cation-pi interactions in biomolecular association. Design of peptides favoring interactions between cationic and aromatic amino acid side chains.
    Pletneva EV; Laederach AT; Fulton DB; Kostic NM
    J Am Chem Soc; 2001 Jul; 123(26):6232-45. PubMed ID: 11427046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformation of cyclic peptides. VII. Cyclic hexapeptides containing the D-Phe-L-Pro sequence.
    Kopple KD; Go A; Schamper TJ; Wilcox CS
    J Am Chem Soc; 1973 Sep; 95(18):6090-6. PubMed ID: 4733832
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of peptidyl-prolyl cis/trans isomerase activity by substrate analog structures: thioxo tetrapeptide-4-nitroanilides.
    Schutkowski M; Wöllner S; Fischer G
    Biochemistry; 1995 Oct; 34(40):13016-26. PubMed ID: 7548060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, biological activity and conformational study of a somatostatin hexapeptide analogue containing a reduced peptide bond.
    Delaet NG; Verheyden P; Velkeniers B; Hooghe-Peters EL; Bruns C; Tourwé D; Van Binst G
    Pept Res; 1993; 6(1):24-30. PubMed ID: 8094990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 1H- and 13C-nuclear magnetic resonance spectroscopy, and its enantioface-differentiating ability.
    Ishizu T; Fujii A; Noguchi S
    Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):235-8. PubMed ID: 8500196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analogues of the cytostatic cyclic tetrapeptide chlamydocin. Synthesis of N beta-(N-maleoylglycyl) and N beta-(tert-butyloxycarbonyl) derivatives of cyclo(Gly-L-Phe-D-Pro-L-Dap).
    Rich DH; Jasensky RD; Mueller GC; Anderson KE
    J Med Chem; 1981 May; 24(5):567-72. PubMed ID: 7241514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Click chemistry as a route to cyclic tetrapeptide analogues: synthesis of cyclo-[Pro-Val-psi(triazole)-Pro-Tyr].
    Bock VD; Perciaccante R; Jansen TP; Hiemstra H; van Maarseveen JH
    Org Lett; 2006 Mar; 8(5):919-22. PubMed ID: 16494474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic peptides. IX. Conformations of a synthetic ion-binding cyclic peptide, cyclo-(pro-gly)3, from circular dichroism and 1H and 13C nuclear magnetic resonance.
    Madison V; Atreyi M; Deber CM; Blout ER
    J Am Chem Soc; 1974 Oct; 96(21):6725-34. PubMed ID: 4412689
    [No Abstract]   [Full Text] [Related]  

  • 39. Solid state structural analysis of the cyclooctapeptide cyclo- (Pro1-Pro-Phe-Phe-Ac6c-Ile-D-Ala-Val8).
    Saviano M; Isernia C; Rossi F; Di Blasio B; Iacovino R; Mazzeo M; Pedone C; Benedetti E
    Biopolymers; 2000 Feb; 53(2):189-99. PubMed ID: 10679623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformational preference and potential templates of N-methylated cyclic pentaalanine peptides.
    Chatterjee J; Mierke DF; Kessler H
    Chemistry; 2008; 14(5):1508-17. PubMed ID: 18080261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.